MassBio Applauds Senators Kerry & Brown for Work on Passage of User Fee Package

May 25, 2012

MassBio applauds Senators John Kerry and Scott Brown for their leadership on the Senate’s overwhelming passage yesterday of the Food and Drug Administration Safety and Innovation Act (FDASIA), which included reauthorization of the Prescription Drug User Fee Act (PDUFA).

“The reauthorization of PDUFA guarantees that Massachusetts’ most innovative companies can continue to develop treatments and cures knowing those products face a rigorous and transparent review process,” said MassBio President & CEO Robert K. Coughlin. “We’d especially like to thank Senators Kerry and Brown for their leadership to ensure patients around the country have access to the cutting-edge therapies our biotechnology companies are working to discover.”

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Upcoming Events email!
For Email Marketing you can trust